RE:RE:RE:RE:RE:RE:RE:RE:RE:So what's considered "Mid" May?StevenBirch wrote: He is talking about the tradeable warrants from the last PP, exercisable at $0.35, being worth $0.65.
And if we do get those valuations from IND I would be happy.
menoalittle wrote: >> Honestly if we hit $1 with .65 warrants off the IND..
what .65 warrants are you talking about? none that I know of.
after the 3.159 mil expiring this month, there's another 3.159 mil (@.50) this Oct, another 4.095 (@.50) next Jan., and then another 4.555 (@.375) in Nov. '21.
And nevermind the .35 warrants for 2024. They're pretty much off the table and parked for a very, very long time. (unless there's a buyout. that'd be a gamechanger.)
Cannabinoid Dr. Mandel concluded by saying that, “This latest preclinical research lays the groundwork for the Company to actively seek strategic partnerships in the co-development of this combined technology for the treatment of specific human cancers, such as GBM. The Company plans to explore these avenues in the
immediate future, with the hopes of securing a joint venture with a company interested in the development of this combination technology, such as a Canadian cannabis producer.”
Im still waiting on this so called avenues to be explored.... do you think after the IND mid may.. that Theralase might secure a JV... or does that come after the 2nd IND is filed for GBM?
2 years you'd think is more than enough 'immediate future'
Just wondering. is the Cannabinoid